Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 31, 2009

Mount Sinai Taps DiscoveryBioMed for Drug Discovery Programs

  • Mount Sinai School of Medicine (MSSM) is employing DiscoveryBioMed (DBM) in fee-for-service contracts covering basic drug discovery work. The agreement calls for human cell optimization, assay optimization, and drug discovery bioassays.

    Experiments have reportedly commenced on assay optimization, and pilot drug screening will begin shortly. The firm is using its expertise in the development and engineering of human cell cultures and lines from normal or diseased tissue.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »